Founded in 2003, Quartesian, now a part of Veranex, is a prominent player in the Education, Health Care, and Pharmaceutical industries, headquartered in the United States. Veranex, known for bringing together best-in-class expertise in product design and engineering, medical device evaluation, clinical development, data management, regulatory, and market access, offers an integrated and comprehensive solution from concept to commercial success.
Quartesian, with a decade-long experience, has been providing clinical data services to its clients, enabling them to take control of their data and clinical trials. Their services are designed to deliver the quality, expertise, and speed necessary to propel trials forward. Whether in need of support in statistical programming, data management, study design, submission, or other areas, Quartesian (now under Veranex) is dedicated to making trials as seamless as possible.
Although specific details regarding the last investment and investors are currently unavailable, Quartesian's collaboration with Veranex positions them as a promising entity in the healthcare and pharmaceutical sectors, leveraging data to drive successful clinical outcomes and commercial achievements.